vtyx: the income statement

MyFinsight

Ventyx Biosciences, Inc. (VTYX)

For the quarter ending 2025-06-30, VTYX made $2,613K in revenue. -$26,893K in net income. Net profit margin of -1029.20%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Unrealized loss on marketable securities	-152
Foreign currency translation	246
Research and development (includes related party amounts of 252, 249, 501 and 503, respectively)	22,266
General and administrative	7,067
Total operating expenses	29,333
Loss from operations	-29,333
Other expense	-21
Interest income	2,367
Total other (income) expense	2,346
Net loss	-26,987
Comprehensive loss	-26,893

Basic net loss per share attributable to common shareholders	-0.38
Diluted net loss per share attributable to common shareholders	-0.38
Weighted average shares of common stock outstanding, basic	71,198,652
Weighted average shares of common stock outstanding, diluted	71,198,652

Unit: Thousand (K) dollars (except for numbers of shares and EPS)